ImmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, today announced that ...
Clinical Trials Arena on MSN
GCAR and Purdue initiate GBM AGILE trial of tinostamustine
The adaptive Phase II/III study is using a master protocol to evaluate multiple therapies with a shared control.
Clinical Trials Arena on MSN
Vir Biotechnology doses first patient in Phase I VIR-5500 trial
The trial is evaluating VIR-5500 with an androgen receptor pathway inhibitor in early-line mCRPC and mHSPC.
According to a study published by The Journal of Pharmacology and Experimental Therapeutics. cannabinoid compounds may help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results